BALTIMORE (KFSN) -- Thirty million Americans, or one in 10, have some form of liver disease. It could be scarring from a hepatitis C infection, cirrhosis or even liver cancer. Doctors are now using a ...
NEW HAVEN, Conn. (WTNH) — In today’s Health Headlines, October is Liver Awareness Month – how a biopsy helps diagnose liver diseases, why fatty liver disease is now on the rise, and how it can ...
The popularity of noninvasive options to diagnose liver disease has been growing, but are there times when more traditional methods like liver biopsy are still needed for a precise diagnosis? Medical ...
Novel biomarker tests have met or exceeded the performance of common lab tests for diagnosing nonalcoholic steatohepatitis (NASH, now known as metabolic dysfunction-associated steatohepatitis or MASH) ...
Fatty liver disease happens when too much fat builds up in the liver. Metabolic dysfunction-associated steatohepatitis (MASH) is a severe type of fatty liver disease where fat buildup causes liver ...
The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their clinical trials. The agency gave a green light to the AI-Based Histologic ...
Hosted on MSN
US FDA approves first AI tool for liver disease trials: How AIM-NASH transforms biopsy reading
The FDA has officially approved the first AI tool to help with liver disease drug trials, and it is designed to make reading liver biopsies for MASH faster, more consistent, and easier for ...
Persistently elevated liver enzymes may be caused by certain types of cancer, including liver, colon, breast, stomach, pancreas, and skin cancers. Liver enzymes are proteins produced by your liver.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback